Modern Organic Chemistry Research
Search of New Scaffolds against N-myristoyltransferase for Antifungal Activity
Download PDF (507.3 KB) PP. 1 - 9 Pub. Date: November 17, 2016
Author(s)
- Sudha Vengurlekar*
Sri Aurobindo Institute of Pharmacy, Indore, India - Reena Gupta
Smriti College of Pharmaceutical Education, Indore, India
Abstract
Keywords
References
[1] Kawasaki, K., Masubuch, M., Morikam, K., Tsujii S. and Ohtsuka T. (2003) Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Bioorganic Medicinal Chemistry Letters, 13, 87-91.
[2] Sogabe, S., Masubuchi, M., Niizuma, S. and Aoki Y. (2002) Crystal structures of Candida albicans N- myristoyltransferase with two distinct inhibitors. Chemistry and Biology, 9,1119-1128.
[3] Bhatnagar, R.S. and Futterer, K. (1998) Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs. Nature Structural Biology, 12, 1091-1097.
[4] Boutin, J.A. (1997) Myristoylation. Cellular Signalling, 1,15-39.
[5] Sogabe, S.M., Sakata, K., Takaai, A., Morikami, K., Shimma, N. and Winkler F. (2002) Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors. Chemical Biology, 9, 1119-1128.
[6] Demirayak, S. and Ucucu, U. (2002) Synthesis and antifungal activities of some aryl (benzofuran-2-yl) ketoximes. Il Farmaco, 57, 609-612.
[7] Rival, Y., Grassy, G., Taudou, A. and Ecalle, R. (1991) Antifungal activity in vitro of some imidazo [l,2- alpyrimidine derivatives. European Journal of Medicinal Chemistry, 26, 13-18.
[8] Silverstri, R. and Artico, M. (2004) Fluoxetine, a Novel Class of anti-Candida Agents. Journal of Medicinal Chemistry, 47, 3924-3926.
[9] Kawasaki, K., Masubuchi, M. and Ohtsuka T.(2003) Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Bioorganic Medicinal Chemistry Letters, 13, 87-91.
[10] Masubuchi, M. , Ebike, H., Liu, P. and Morikami, K. (2003)Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase. Bioorganic Medicinal Chemistry, 11, 4463-4478.
[11] Wahab, K.M., Jahangir, A.M., Rashid, M.A. and Chowdhary, R. (2005) A new structural alternative in benzo[b]furans for antimicrobial activity. Bioorganic Medicinal Chemistry Letters, 13, 4796-4805.
[12] Karaburn, N.G. and Benkil, K.(2006) Synthesis and activities of some aryl [3-(imidazol-1-yl/triazol-1-yl methyle) benzofuran-2-yl]ketoximes. European Journal of Medicinal Chemistry, 41, 651-656.
[13] ZHU Jie, SHENG Chun-Quan, ZHANG Min, SONG Yun-Long, CHEN Jun, YU Jian-Xin, YAO Jian-Zhong, MIAO Zhen-Yuan and ZHANG Wan-Nian. (2006) 3D-QSAR Study of a Series of Novel Benzofuran NMT Inhibitors, Chemical Journal of Chinese Universities, 27, 287-29
[14] Kirimis, C., Koca, M., Servi, S. and Gur, S. (2009) Synthesis and antimicrobial activity of dinapthol [2,1- b]furan-2-yl-methanone and their oxime derivatives. Turkey Journal of Chemistry, 33, 374-380.
[15] Reddy, C.S. and Nagaraj, A. J.(2008) Synthesis and biological study of novel bis-chalcones, bis-thiazines and Bis-pyrimidines. Iranian Chemical Society, 5, 262-267.
[16] NCCLS, National Committee for Clinical Laboratory Standards. 2002, In Method M27-A2, 2nd ed.: Wayne, Ed.; Vol. 22, pp 1–29. In NCCLS, and method M-38A, 2nd ed.: Wayne Ed.; Vol. 22, pp 1–27.